Dual inhibition of AKT ‐m TOR and AR signaling by targeting HDAC 3 in  PTEN  ‐ or  SPOP  ‐mutated prostate cancer

Yan, Yuqian; An, Jian; Yang, Yinhui; Wu, Di; Bai, Yang; Cao, William; Ma, Linlin; Chen, Junhui; Yu, Zhendong; He, Yundong; Jin, Xin; Pan, Yunqian; Ma, Tao; Wang, Shangqian; Hou, Xiaonan; Weroha, Saravut John; Karnes, R. Jeffrey; Zhang, Jun; Westendorf, Jennifer J.; Wang, Liguo; Chen, Yu; Xu, Wanhai; Zhu, Runzhi; Wang, Dejie; Huang, Haojie

Published in

Wiley Open Access, EMBO Molecular Medicine, 4(10), 2018

DOI: 10.15252/emmm.201708478

Tools

Export citation

Search in Google Scholar

Dual inhibition of AKT ‐m TOR and AR signaling by targeting HDAC 3 in PTEN ‐ or SPOP ‐mutated prostate cancer

Journal article published in 2018 by Yuqian Yan, Jian An, Yinhui Yang, Di Wu, Yang Bai, William Cao, Linlin Ma, Junhui Chen, Zhendong Yu, Yundong He, Xin Jin, Yunqian Pan, Tao Ma, Shangqian Wang, Xiaonan Hou and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Dual inhibition of AKT ‐m TOR and AR signaling by targeting HDAC 3 in PTEN ‐ or SPOP ‐mutated prostate cancer